Search Results

There are 303337 results for: content related to: PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus–related systemic vasculitis

  1. You have free access to this content
    Antiviral therapy for hepatitis C virus–associated mixed cryoglobulinemia vasculitis: A long-term followup study

    Arthritis & Rheumatism

    Volume 54, Issue 11, November 2006, Pages: 3696–3706, David Saadoun, Mathieu Resche-Rigon, Vincent Thibault, Jean-Charles Piette and Patrice Cacoub

    Article first published online : 30 OCT 2006, DOI: 10.1002/art.22168

  2. You have free access to this content
    Impact of weight-based ribavirin with peginterferon alfa-2b in african americans with hepatitis C virus genotype 1

    Hepatology

    Volume 46, Issue 4, October 2007, Pages: 982–990, Ira M. Jacobson, Robert S. Brown Jr, Jonathan McCone, Martin Black, Clive Albert, Michael S. Dragutsky, Firdous A. Siddiqui, Thomas Hargrave, Paul Y. Kwo, Louis Lambiase, Greg W. Galler, Victor Araya, Bradley Freilich, Joann Harvey, Louis H. Griffel and Clifford A. Brass

    Article first published online : 25 SEP 2007, DOI: 10.1002/hep.21670

  3. You have free access to this content
    Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: Systematic review of randomized trials

    Hepatology

    Volume 51, Issue 4, April 2010, Pages: 1176–1184, Tahany Awad, Kristian Thorlund, Goran Hauser, Davor Stimac, Mahasen Mabrouk and Christian Gluud

    Article first published online : 23 DEC 2009, DOI: 10.1002/hep.23504

  4. You have free access to this content
    Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: A randomized trial

    Hepatology

    Volume 46, Issue 4, October 2007, Pages: 971–981, Ira M. Jacobson, Robert S. Brown Jr, Bradley Freilich, Nezam Afdhal, Paul Y. Kwo, John Santoro, Scott Becker, Adil E. Wakil, David Pound, Eliot Godofsky, Robert Strauss, David Bernstein, Steven Flamm, Mary Pat Pauly, Pabak Mukhopadhyay, Louis H. Griffel and Clifford A. Brass

    Article first published online : 25 SEP 2007, DOI: 10.1002/hep.21932

  5. You have free access to this content
    Diagnosis, management, and treatment of hepatitis C: An update

    Hepatology

    Volume 49, Issue 4, April 2009, Pages: 1335–1374, Marc G. Ghany, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Article first published online : 2 DEC 2008, DOI: 10.1002/hep.22759

  6. You have free access to this content
    Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trial

    Hepatology

    Volume 47, Issue 1, January 2008, Pages: 43–50, Alessandra Mangia, Nicola Minerva, Donato Bacca, Raffaele Cozzolongo, Giovanni L. Ricci, Vito Carretta, Francesco Vinelli, Gaetano Scotto, Giuseppe Montalto, Mario Romano, Giuseppe Cristofaro, Leonardo Mottola, Fulvio Spirito and Angelo Andriulli

    Article first published online : 10 DEC 2007, DOI: 10.1002/hep.22061

  7. You have free access to this content
    Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results

    Hepatology

    Volume 49, Issue 6, June 2009, Pages: 1838–1846, Bruce R. Bacon, Mitchell L. Shiffman, Flavia Mendes, Reem Ghalib, Tarek Hassanein, Giuseppe Morelli, Shobha Joshi, Kenneth Rothstein, Paul Kwo and Norman Gitlin

    Article first published online : 2 FEB 2009, DOI: 10.1002/hep.22871

  8. You have free access to this content
    A viral kinetic study using pegylated interferon alfa-2b and/or lamivudine in patients with chronic hepatitis B/HBeAg negative

    Hepatology

    Volume 42, Issue 1, July 2005, Pages: 77–85, Vassiliki-Anastasia Sypsa, Konstantinos Mimidis, Nicholas C. Tassopoulos, Dimitrios Chrysagis, Themistoklis Vassiliadis, Antonios Moulakakis, Maria Raptopoulou, Caterina Haida and Angelos Hatzakis

    Article first published online : 16 JUN 2005, DOI: 10.1002/hep.20738

  9. You have free access to this content
    Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and peginterferon/ribavirin

    Hepatology

    Volume 56, Issue 2, August 2012, Pages: 567–575, Ira M. Jacobson, Patrick Marcellin, Stefan Zeuzem, Mark S. Sulkowski, Rafael Esteban, Fred Poordad, Savino Bruno, Margaret H. Burroughs, Lisa D. Pedicone, Navdeep Boparai, Weiping Deng, Mark J. DiNubile, Keith M. Gottesdiener, Clifford A. Brass, Janice K. Albrecht and Jean-Pierre Bronowicki

    Article first published online : 29 JUN 2012, DOI: 10.1002/hep.25865

  10. You have free access to this content
    A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance

    Hepatology

    Volume 40, Issue 1, July 2004, Pages: 120–124, Stefan Mauss, Florian Berger, Joerg Goelz, Bernhard Jacob and Günther Schmutz

    Article first published online : 30 JUN 2004, DOI: 10.1002/hep.20279

  11. Comparison of the efficacy of ribavirin plus peginterferon alfa-2b for chronic hepatitis C infection in patients with and without coagulation disorders

    Journal of Medical Virology

    Volume 85, Issue 2, February 2013, Pages: 228–234, Takashi Honda, Yoshiaki Katano, Teiji Kuzuya, Kazuhiko Hayashi, Masatoshi Ishigami, Akihiro Itoh, Yoshiki Hirooka, Isao Nakano, Tetsuya Ishikawa, Hidenori Toyoda, Takashi Kumada, Koji Yamamoto, Tadashi Matsushita, Tetsuhito Kojima, Junki Takamatsu and Hidemi Goto

    Article first published online : 14 NOV 2012, DOI: 10.1002/jmv.23444

  12. You have free access to this content
    Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen–positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline

    Hepatology

    Volume 52, Issue 4, October 2010, Pages: 1251–1257, Milan J. Sonneveld, Vincent Rijckborst, Charles A. B. Boucher, Bettina E. Hansen and Harry L. A. Janssen

    Article first published online : 29 JUL 2010, DOI: 10.1002/hep.23844

  13. An open-safety study of dual antiviral therapy in real-world patients with chronic hepatitis C

    Pharmacoepidemiology and Drug Safety

    Volume 19, Issue 11, November 2010, Pages: 1113–1123, Fabio Tinè, Domenico Graviano, Gandolfo Giannuoli, Salvatore Madonia, Giuseppe Malizia, Salvatore Patti, Salvatore Fasola, Mario Cottone and Gennaro D'Amico

    Article first published online : 16 SEP 2010, DOI: 10.1002/pds.2025

  14. You have free access to this content
    An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

    Hepatology

    Volume 54, Issue 4, October 2011, Pages: 1433–1444, Marc G. Ghany, David R. Nelson, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Article first published online : 26 SEP 2011, DOI: 10.1002/hep.24641

  15. You have free access to this content
    A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results

    Hepatology

    Volume 50, Issue 3, September 2009, Pages: 717–726, Yves Benhamou, Nezam H. Afdhal, David R. Nelson, Mitchell L. Shiffman, Deanine G. Halliman, Jamie Heise, Eric Chun and Paul J. Pockros

    Article first published online : 11 MAY 2009, DOI: 10.1002/hep.23073

  16. You have free access to this content
    High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials

    Hepatology

    Volume 56, Issue 6, December 2012, Pages: 2039–2050, Patrick Marcellin, Hugo Cheinquer, Manuela Curescu, Geoffrey M. Dusheiko, Peter Ferenci, Andrzej Horban, Donald Jensen, Gabriella Lengyel, Alessandra Mangia, Denis Ouzan, Massimo Puoti, Maribel Rodriguez-Torres, Mitchell L. Shiffman, Manuela Schmitz, Fernando Tatsch and Mario Rizzetto

    Article first published online : 8 AUG 2012, DOI: 10.1002/hep.25892

  17. You have free access to this content
    Determinants of relapse after a short (12 weeks) course of antiviral therapy and re-treatment efficacy of a prolonged course in patients with chronic hepatitis C virus genotype 2 or 3 infection

    Hepatology

    Volume 49, Issue 2, February 2009, Pages: 358–363, Alessandra Mangia, Nicola Minerva, Donato Bacca, Raffaele Cozzolongo, Ernesto Agostinacchio, Fernando Sogari, Gaetano Scotto, Francesco Vinelli, Giovanni Luciano Ricci, Mario Romano, Vito Carretta, Daniela Petruzzellis and Angelo Andriulli

    Article first published online : 9 OCT 2008, DOI: 10.1002/hep.22679

  18. You have free access to this content
    Randomized trial comparing pegylated interferon α-2b versus pegylated interferon α-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients

    Hepatology

    Volume 49, Issue 1, January 2009, Pages: 22–31, Montserrat Laguno, Carmen Cifuentes, Javier Murillas, Sergio Veloso, Maria Larrousse, Antoni Payeras, Lucia Bonet, Francese Vidal, Ana Milinkovic, Antoni Bassa, Concha Villalonga, Iñaki Pérez, Cristina Tural, Maria Martínez-Rebollar, Marta Calvo, Jose Luis Blanco, Estaban Martínez, Jose M. Sánchez-Tapias, Jose M. Gatell and Jose Mallolas

    Article first published online : 9 SEP 2008, DOI: 10.1002/hep.22598

  19. You have free access to this content
    Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial

    Hepatology

    Volume 57, Issue 3, March 2013, Pages: 974–984, Mark S. Sulkowski, Fred Poordad, Michael P. Manns, Jean-Pierre Bronowicki, K. Rajender Reddy, Stephen A. Harrison, Nezam H. Afdhal, Heather L. Sings, Lisa D. Pedicone, Kenneth J. Koury, Vilma Sniukiene, Margaret H. Burroughs, Janice K. Albrecht, Clifford A. Brass, Ira M. Jacobson and for the SPRINT-2 Trial Investigators

    Article first published online : 11 FEB 2013, DOI: 10.1002/hep.26096

  20. You have free access to this content
    Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C

    Hepatology

    Volume 41, Issue 5, May 2005, Pages: 1013–1018, Stefan Wirth, Heidrun Pieper-Boustani, Thomas Lang, Antje Ballauff, Ulrike Kullmer, Patrick Gerner, Philip Wintermeyer and Andreas Jenke

    Article first published online : 25 MAR 2005, DOI: 10.1002/hep.20661